Insider Buying: INOVIQ Ltd (ASX:IIQ) Insider Acquires A$56,756.35 in Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston acquired 162,161 shares of the firm’s stock in a transaction on Friday, March 7th. The shares were bought at an average cost of A$0.35 ($0.22) per share, with a total value of A$56,756.35 ($35,921.74).

INOVIQ Stock Performance

The company has a quick ratio of 9.52, a current ratio of 7.07 and a debt-to-equity ratio of 2.02. The stock has a market capitalization of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04.

INOVIQ Company Profile

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.